How to Get Retatrutide: The Honest Answer

There is no legitimate retail route to retatrutide, and the reason is simple: it is not an approved drug. No pharmacy stocks it, no doctor can prescribe it, and no insurer covers it — because there is no approved product for any of those things to attach to.

That leaves two routes, and they are not equivalent.

Route 1: clinical trial enrolment

This is the only lawful way to receive retatrutide. Eli Lilly is running a phase 3 programme, and trials recruit participants who meet defined criteria.

Route 2: the research-chemical market

Retatrutide is widely sold online under a research-use-only designation — a legal statement that the product is not for human or veterinary use. It is not a quality grade and confers nothing.

Routes that do not exist

1. Compounded retatrutide. Compounding permission applies to approved drugs in shortage. An unapproved investigational drug cannot be compounded on that basis at all — so any "compounded retatrutide" offer describes something with no lawful route to exist.

2. A telehealth prescription. There is no approved product to prescribe. A service offering to prescribe it is offering something else, or something unlawful.

3. Importing it for personal use. Personal importation policies concern approved drugs unavailable domestically, not investigational compounds.

4. Expanded access or compassionate use. These programmes exist for serious or life-threatening conditions where no alternative therapy exists. Obesity has approved treatments, which is precisely why the criteria are unlikely to be met.

The approved alternatives

This is the part most often skipped in the rush to obtain an unapproved compound. Two drugs in the same broad class are approved, available and extensively studied:

A 2026 BMJ network meta-analysis compared drugs for adults with overweight or obesity, which is the kind of evidence base an approved option carries and an investigational one does not. See tirzepatide vs semaglutide and retatrutide vs tirzepatide.

If waiting is the plan

Approval requires completed phase 3 trials, a safety database large enough to characterise uncommon events, a submitted application, FDA review and manufacturing inspection. None of those steps has a publicly reliable completion date.

Any specific approval date circulating online is a projection, not information. The FDA approval status guide sets out what remains, and the cost guide covers what the grey market charges in the meantime.